BRCA1 and breast carcinoma: The aim of this study was to assess if an association between As levels and cancer risk also exists among women harboring mutations in BRCA1. We found that women with As blood levels above the median (0.85 μg/L) had a significant 2-fold increased risk of developing breast cancer.